AFX — Carl Zeiss Meditec AG Share Price
0.000.00%
Last trade - 00:00- €4.95bn
- €5.54bn
- €2.07bn
- 68
- 14
- 29
- 26
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 26.12 | ||
| PEG Ratio (f) | 2.53 | ||
| EPS Growth (f) | 11.51% | ||
| Dividend Yield (f) | 1.34% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.43 | ||
| Price to Tang. Book | 14.06 | ||
| Price to Free Cashflow | 52.09 | ||
| Price to Sales | 2.38 | ||
| EV to EBITDA | 30.96 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.34% | ||
| Return on Equity | 7.48% | ||
| Operating Margin | 8.6% | ||
Financial Summary
| Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 1,335.45 | 1,646.79 | 1,902.84 | 2,089.3 | 2,066.13 | 2,192.77 | 2,346.38 | 7.2% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -22.44 | +85.18 | +25.3 | -1.2 | -38.05 | -6.14 | +26.85 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Carl Zeiss Meditec AG is a Germany-based medical technology and device company. The Company offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The Company offers related support services.
Directors
- Ludwin Monz CMG (57)
- Karl Lamprecht NEC
- Tania Von Der Goltz VSU
- Justus Wehmer CFO (56)
- Jan De Cler CHO
- Markus Guthoff IND (56)
- Isabel De Paoli SUB
- Rene Denner SUB
- Cornelia Grandy SUB
- Peter Kameritsch SUB
- Jeffrey Marx SUB
- Christian Muller SUB
- Torsten Reitze SUB
- Last Annual
- September 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 30th, 1995
- Public Since
- March 20th, 2000
- No. of Employees
- 5,730
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- XETRA
- Shares in Issue
- 87,536,079
- Address
- Goeschwitzer Strasse 51-52, JENA, 07745
- Web
- https://www.zeiss.de/meditec-ag/
- Phone
- +49 3641220331
- Contact
- Sebastian Frericks
- Auditors
- PricewaterhouseCoopers GMBH Wirtschaftsprüfungsgesellschaft
Upcoming Events for AFX
Q2 2025 Carl Zeiss Meditec AG Earnings Release
Q3 2025 Carl Zeiss Meditec AG Earnings Release
Similar to AFX
FAQ
What is the Carl Zeiss Meditec AG share price?
As of Today at 19:48 UTC, shares in Carl Zeiss Meditec AG are trading at €56.60. This share price information is delayed by 15 minutes.
How has the Carl Zeiss Meditec AG share price performed this year?
Shares in Carl Zeiss Meditec AG last closed at €56.60 and the price had moved by -41.38% over the past 365 days. In terms of relative price strength the Carl Zeiss Meditec AG share price has underperformed the FTSE Global All Cap Index by -42.41% over the past year.
What are the analyst and broker recommendations for Carl Zeiss Meditec AG?
The overall consensus recommendation for Carl Zeiss Meditec AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Carl Zeiss Meditec AG dividend yield?
The Carl Zeiss Meditec AG dividend yield is 1.06% based on the trailing twelve month period.
Does Carl Zeiss Meditec AG pay a dividend?
Last year, Carl Zeiss Meditec AG paid a total dividend of €0.60, and it currently has a trailing dividend yield of 1.06%. We do not have any data on when Carl Zeiss Meditec AG is to next pay dividends.
When does Carl Zeiss Meditec AG next pay dividends?
We do not have data on when Carl Zeiss Meditec AG is to next pay dividends. The historic dividend yield on Carl Zeiss Meditec AG shares is currently 1.06%.
How do I buy Carl Zeiss Meditec AG shares?
To buy shares in Carl Zeiss Meditec AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Carl Zeiss Meditec AG?
As of the previous close price of €56.60, shares in Carl Zeiss Meditec AG had a market capitalisation of €4.95bn.
Where are Carl Zeiss Meditec AG shares listed?
Here are the trading details for Carl Zeiss Meditec AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: AFX
What kind of share is Carl Zeiss Meditec AG?
Based on an overall assessment of its quality, value and momentum Carl Zeiss Meditec AG is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Carl Zeiss Meditec AG share price forecast for 2025?
The analyst consensus target price for shares in Carl Zeiss Meditec AG is €62.70. That is 10.78% above the last closing price of €56.60.
Analysts covering Carl Zeiss Meditec AG currently have a consensus Earnings Per Share (EPS) forecast of €1.89 for the next financial year.
Find out moreWhat is the trend in the Carl Zeiss Meditec AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Carl Zeiss Meditec AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -10.4%.
As of the last closing price of €56.60, shares in Carl Zeiss Meditec AG were trading -3.7% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Carl Zeiss Meditec AG PE Ratio?
The Carl Zeiss Meditec AG PE ratio based on its reported earnings over the past 12 months is 26.12. The shares last closed at €56.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Carl Zeiss Meditec AG?
Carl Zeiss Meditec AG's management team is headed by:
- Ludwin Monz - CMG
- Karl Lamprecht - NEC
- Tania Von Der Goltz - VSU
- Justus Wehmer - CFO
- Jan De Cler - CHO
- Markus Guthoff - IND
- Isabel De Paoli - SUB
- Rene Denner - SUB
- Cornelia Grandy - SUB
- Peter Kameritsch - SUB
- Jeffrey Marx - SUB
- Christian Muller - SUB
- Torsten Reitze - SUB